We protect your health through science
Investigación
Epidemiología del Cáncer y Ambiental
Publicaciones destacadas
Características epidemiológicas de los brotes de hepatitis A en España (años 2015-2019)
13. Guerrero-Vadillo M, Peñuelas Martínez M, Varela Martínez C. Características epidemiológicas de los brotes de hepatitis A en España (años 2015-2019). BES [Internet]. 24 de enero de 2022 ;29(2). Disponible en: //revista.isciii.es/index.php/bes/article/view/1124
PUBMED DOIMarkers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV. v
Izquierdo R, Vallejo A, Suárez-García I, Martín-Hondarza A, Gutierrez F, Perez-Molina JA, García DV, Macías J, Rivero A, Olalla J, Montero-Alonso M, Asensi V, Moreno S, Jarrín I, Rava M; CoRIS cohort. J Acquir Immune Defic Syndr. 2025 Apr 7.
PUBMED DOICOVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lanièce Delaunay C, Martínez-Baz I, Sève N, Domegan L, Mazagatos C, Buda S, et al. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2024 Mar;29(13).
PUBMED DOITrends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009
Diez M, Bleda MJ, Varela JR, Ordoñana J, Azpiri MA, Vall M, Santos C, Viloria L, de Armas C, Urena JM, Trullen J, Pueyo I, Martinez B, Puerta T, Vera M, Sanz I, Junquera ML, Landa MC, Martinez E, Camara MM, Belda J, Bru FJ, Diaz A; EPI-VIH Study Group. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009. Euro Surveill. 2014;19 (47):20971.
PUBMED DOI